A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma
2024

Prognostic Model for Cisplatin Resistance in Oral Cancer

Sample size: 255 publication Evidence: high

Author Information

Author(s): Lu Rong, Yang Qian, Liu Siyu, Sun Lu

Primary Institution: Shengli Oilfield Central Hospital, Dongying, Shandong, China

Hypothesis

This study aims to screen for a cisplatin-resistance related prognostic signature in oral squamous cell carcinoma (OSCC) and assess its correlation with the immune microenvironment.

Conclusion

The identified model genes and immune cells may help predict prognosis and chemoresistance in OSCC.

Supporting Evidence

  • Seven drug-resistant genes were identified as independent prognostic factors.
  • Fifteen immune cells showed statistically significant differences in infiltration levels between risk groups.
  • The study constructed a risk score model to predict survival rates.

Takeaway

Researchers found some genes that can help predict how well patients with oral cancer will respond to a common treatment called cisplatin.

Methodology

Gene expression data were analyzed using univariate Cox regression and LASSO regression to construct a survival prognosis model.

Participant Demographics

The study included 255 OSCC samples with survival and clinical information.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3290/j.ohpd.b4836127

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication